Frontline, fixed-duration venetoclax/obinutuzumab: PFS and MRD data from CLL14 VJHemOnc – Video Journal of Hematology & HemOnc 1:12 5 years ago 115 Далее Скачать
Fixed-duration therapy with venetoclax-obinutuzumab in frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 10:24 5 years ago 1 736 Далее Скачать
Six-year update from CLL14: fixed-duration venetoclax + obinutuzumab for previously untreated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 296 Далее Скачать
CLL14: feasibility of fixed-duration frontline therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 2 years ago 164 Далее Скачать
CLL14: venetoclax-obinutuzumab improves PFS and MRD in untreated, reduced fitness CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:16 5 years ago 280 Далее Скачать
The future of fixed-duration therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 127 Далее Скачать
Fixed-duration treatment strategies for frontline and relapsed CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:56 1 year ago 172 Далее Скачать
Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with previously untreat... ecancer 10:45 5 years ago 103 Далее Скачать
CLL14 trial: do certain patients benefit more from venetoclax plus obinutuzumab in CLL? Lymphoma Hub 3:08 5 years ago 586 Далее Скачать
5-year follow-up results of CLL14: obinutuzumab + venetoclax vs obinutuzumab + chlorambucil in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:59 2 years ago 745 Далее Скачать
Comment on fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbidities ecancer 1:26 5 years ago 60 Далее Скачать
New Data Supports Long Term Efficacy of Venetoclax-Obinutuzumab for CLL Patients CheckRare 8:46 4 years ago 567 Далее Скачать
Dr. Al-Sawaf on Updated PFS Data With Venetoclax Plus Obinutuzumab in CLL OncLive 1:46 4 years ago 355 Далее Скачать
CLL14: Venetoclax plus obinutuzumab for CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:54 3 years ago 983 Далее Скачать
CLL14 trial thoughts VJHemOnc – Video Journal of Hematology & HemOnc 1:14 5 years ago 99 Далее Скачать
6-year results of CLL14: venetoclax-obinutuzumab for previously untreated CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:59 1 year ago 2 019 Далее Скачать
What Is the Best Strategy for Frontline Venetoclax Plus Obinutuzumab in CLL? Blood Cancers Today 0:37 1 year ago 200 Далее Скачать
